Expert Interview
Checking on the Launch of Xpovio in relapsed refractory multiple myeloma and relapsed or refractory diffuse large B-cell lymphoma
Ticker(s): KPTIInstitution: Georgetown University
- Director of the Stem Cell Transplant and Cellular Immunotherapy program at MedStar Georgetown University Hospital and a professor of Medicine at Georgetown University
- Manages 20+ patients with Multiple Myeloma
- Myeloma Division and Director, Myeloma Research at John Theurer Cancer Center. Research focused on plasma cell dyscrasias (multiple myeloma, monoclonal gammopathy of undetermined significance, amyloidosis, Waldenstrom's macroglolinemia)
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
